Cargando…

A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent

PURPOSE: Intra-operative management of the surgical margin in patients diagnosed with head and neck squamous cell carcinoma (HNSCC) remains challenging as surgeons still have to rely on visual and tactile information. Fluorescence-guided surgery using tumor-specific imaging agents can assist in clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinkamp, Pieter Jan, Voskuil, Floris Jan, van der Vegt, Bert, Doff, Jan Johannes, Schepman, Kees-Pieter, de Visscher, Sebastiaan Antonius Hendrik Johannes, Kelder, Wendy, Jayalakshmi, Yalia, Gao, Jinming, Sumer, Baran Devrim, van Dam, Gooitzen Michell, Witjes, Max Johannes Hendrikus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578180/
https://www.ncbi.nlm.nih.gov/pubmed/34031845
http://dx.doi.org/10.1007/s11307-021-01614-z
_version_ 1784596220717563904
author Steinkamp, Pieter Jan
Voskuil, Floris Jan
van der Vegt, Bert
Doff, Jan Johannes
Schepman, Kees-Pieter
de Visscher, Sebastiaan Antonius Hendrik Johannes
Kelder, Wendy
Jayalakshmi, Yalia
Gao, Jinming
Sumer, Baran Devrim
van Dam, Gooitzen Michell
Witjes, Max Johannes Hendrikus
author_facet Steinkamp, Pieter Jan
Voskuil, Floris Jan
van der Vegt, Bert
Doff, Jan Johannes
Schepman, Kees-Pieter
de Visscher, Sebastiaan Antonius Hendrik Johannes
Kelder, Wendy
Jayalakshmi, Yalia
Gao, Jinming
Sumer, Baran Devrim
van Dam, Gooitzen Michell
Witjes, Max Johannes Hendrikus
author_sort Steinkamp, Pieter Jan
collection PubMed
description PURPOSE: Intra-operative management of the surgical margin in patients diagnosed with head and neck squamous cell carcinoma (HNSCC) remains challenging as surgeons still have to rely on visual and tactile information. Fluorescence-guided surgery using tumor-specific imaging agents can assist in clinical decision-making. However, a standardized imaging methodology is lacking. In this study, we determined whether a standardized, specimen-driven, fluorescence imaging framework using ONM-100 could assist in clinical decision-making during surgery. PROCEDURES: Thirteen patients with histologically proven HNSCC were included in this clinical study and received ONM-100 24 ± 8 h before surgery. Fluorescence images of the excised surgical specimen and of the surgical cavity were analyzed. A fluorescent lesion with a tumor-to-background ratio (TBR) > 1.5 was considered fluorescence-positive and correlated to standard of care (SOC) histopathology. RESULTS: All six tumor-positive surgical margins were detected immediately after excision using fluorescence-guided intra-operative imaging. Postoperative analysis showed a median TBR (±IQR) of the fluorescent lesions on the resection margin of 3.36 ± 1.62. Three fluorescence-positive lesions in the surgical cavity were biopsied and showed occult carcinoma and severe dysplasia, and a false-positive fluorescence lesion. CONCLUSION: Our specimen-driven fluorescence framework using a novel, pH-activatable, fluorescent imaging agent could assist in reliable and real-time adequate clinical decision-making showing that a fluorescent lesion on the surgical specimen with a TBR of 1.5 is correlated to a tumor-positive resection margin. The binary mechanism of ONM-100 allows for a sharp tumor delineation in all patients, giving the surgeon a clinical tool for real-time margin assessment, with a high sensitivity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11307-021-01614-z.
format Online
Article
Text
id pubmed-8578180
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85781802021-11-15 A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent Steinkamp, Pieter Jan Voskuil, Floris Jan van der Vegt, Bert Doff, Jan Johannes Schepman, Kees-Pieter de Visscher, Sebastiaan Antonius Hendrik Johannes Kelder, Wendy Jayalakshmi, Yalia Gao, Jinming Sumer, Baran Devrim van Dam, Gooitzen Michell Witjes, Max Johannes Hendrikus Mol Imaging Biol Research Article PURPOSE: Intra-operative management of the surgical margin in patients diagnosed with head and neck squamous cell carcinoma (HNSCC) remains challenging as surgeons still have to rely on visual and tactile information. Fluorescence-guided surgery using tumor-specific imaging agents can assist in clinical decision-making. However, a standardized imaging methodology is lacking. In this study, we determined whether a standardized, specimen-driven, fluorescence imaging framework using ONM-100 could assist in clinical decision-making during surgery. PROCEDURES: Thirteen patients with histologically proven HNSCC were included in this clinical study and received ONM-100 24 ± 8 h before surgery. Fluorescence images of the excised surgical specimen and of the surgical cavity were analyzed. A fluorescent lesion with a tumor-to-background ratio (TBR) > 1.5 was considered fluorescence-positive and correlated to standard of care (SOC) histopathology. RESULTS: All six tumor-positive surgical margins were detected immediately after excision using fluorescence-guided intra-operative imaging. Postoperative analysis showed a median TBR (±IQR) of the fluorescent lesions on the resection margin of 3.36 ± 1.62. Three fluorescence-positive lesions in the surgical cavity were biopsied and showed occult carcinoma and severe dysplasia, and a false-positive fluorescence lesion. CONCLUSION: Our specimen-driven fluorescence framework using a novel, pH-activatable, fluorescent imaging agent could assist in reliable and real-time adequate clinical decision-making showing that a fluorescent lesion on the surgical specimen with a TBR of 1.5 is correlated to a tumor-positive resection margin. The binary mechanism of ONM-100 allows for a sharp tumor delineation in all patients, giving the surgeon a clinical tool for real-time margin assessment, with a high sensitivity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11307-021-01614-z. Springer International Publishing 2021-05-24 2021 /pmc/articles/PMC8578180/ /pubmed/34031845 http://dx.doi.org/10.1007/s11307-021-01614-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Steinkamp, Pieter Jan
Voskuil, Floris Jan
van der Vegt, Bert
Doff, Jan Johannes
Schepman, Kees-Pieter
de Visscher, Sebastiaan Antonius Hendrik Johannes
Kelder, Wendy
Jayalakshmi, Yalia
Gao, Jinming
Sumer, Baran Devrim
van Dam, Gooitzen Michell
Witjes, Max Johannes Hendrikus
A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent
title A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent
title_full A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent
title_fullStr A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent
title_full_unstemmed A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent
title_short A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent
title_sort standardized framework for fluorescence-guided margin assessment for head and neck cancer using a tumor acidosis sensitive optical imaging agent
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578180/
https://www.ncbi.nlm.nih.gov/pubmed/34031845
http://dx.doi.org/10.1007/s11307-021-01614-z
work_keys_str_mv AT steinkamppieterjan astandardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT voskuilflorisjan astandardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT vandervegtbert astandardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT doffjanjohannes astandardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT schepmankeespieter astandardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT devisschersebastiaanantoniushendrikjohannes astandardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT kelderwendy astandardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT jayalakshmiyalia astandardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT gaojinming astandardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT sumerbarandevrim astandardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT vandamgooitzenmichell astandardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT witjesmaxjohanneshendrikus astandardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT steinkamppieterjan standardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT voskuilflorisjan standardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT vandervegtbert standardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT doffjanjohannes standardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT schepmankeespieter standardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT devisschersebastiaanantoniushendrikjohannes standardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT kelderwendy standardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT jayalakshmiyalia standardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT gaojinming standardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT sumerbarandevrim standardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT vandamgooitzenmichell standardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent
AT witjesmaxjohanneshendrikus standardizedframeworkforfluorescenceguidedmarginassessmentforheadandneckcancerusingatumoracidosissensitiveopticalimagingagent